longbridgelongbridge
  • 平台特色
    特色
    投资产品私人财富管理交易工具行情服务分析工具资讯服务开发者平台
    账户类型
    个人客户机构客户
  • Café
longbridge
© 2026 Longbridge|服务条款隐私政策

Xenetic Biosciences

XBIO

----
开始交易
概览概览新闻新闻讨论讨论财务财务预测预测估值估值股东股东简况简况
LongbridgeAI
全部股东机构持有者内部人士

全部股东

股东类型

  • 公众及其他79.15%
  • 个人与内部人士7.98%
  • 私营企业6.33%
  • 对冲基金5.01%
  • 机构投资者1.53%

主要股东

主要股东 最新
股东
CLS Therapeutics, Inc.
6.29%14.75 万0.14%+02026/03/31
Renaissance Technologies LLC
5.01%11.74 万0.99%-2.00 万2026/06/30
James ParslowCFO, COO, Interim CEO & Corporate Secretary
4.27%10.00 万4.27%+10.00 万2026/04/21
Dmitry GenkinChairman
2.92%6.85 万0.07%+02026/03/31
Alexey Vinogradov
0.80%1.87 万0.02%+02026/03/31
Geode Capital Management, LLC
0.74%1.74 万0.19%-4,018.002026/06/30
Vanguard Capital Management, LLC
0.54%1.27 万0.25%+5,950.002026/06/30
Royal Bank of Canada Trust Company (Bahamas) Limited
0.12%2,700.00<0.01%+02026/06/30
FMR LLC
0.05%1,286.000.04%-784.002026/06/30
SBI Holdings, Inc.
0.04%1,000.000.04%+1,000.002026/06/30
Tower Research Capital Europe Limited
0.03%696.00<0.01%-110.002026/06/30
Morgan Stanley
<0.01%150.00<0.01%+150.002026/06/30
Darwin Wealth Management, LLC
<0.01%2.000.00%+02026/06/30
Grigory BorisenkoIndependent Non-Executive Director
0.00%0.000.00%+02026/03/31
Firdaus DastoorIndependent Director
0.00%0.000.00%+02026/03/31
Roger KornbergIndependent Director
0.00%0.000.00%+02026/03/31
Moshe MizrahyIndependent Non Executive Director
0.00%0.000.00%+02026/03/31
Mjl Manager Llc
0.00%0.003.99%-9.36 万2026/09/16